J I Geh

2.3k total citations
32 papers, 1.7k citations indexed

About

J I Geh is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, J I Geh has authored 32 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 16 papers in Pulmonary and Respiratory Medicine and 15 papers in Oncology. Recurrent topics in J I Geh's work include Colorectal and Anal Carcinomas (11 papers), Gastric Cancer Management and Outcomes (11 papers) and Colorectal Cancer Surgical Treatments (10 papers). J I Geh is often cited by papers focused on Colorectal and Anal Carcinomas (11 papers), Gastric Cancer Management and Outcomes (11 papers) and Colorectal Cancer Surgical Treatments (10 papers). J I Geh collaborates with scholars based in United Kingdom, Australia and Denmark. J I Geh's co-authors include A. Hartley, Rob Glynne‐Jones, Christopher C. McConkey, A. Crellin, Matthew A. Clark, Søren M. Bentzen, Simon Bond, Paul Sanghera, Douglas W. Wong and David Cunningham and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Annals of Surgery and The Lancet Oncology.

In The Last Decade

J I Geh

31 papers receiving 1.7k citations

Peers

J I Geh

SURGE

PRM

ONCOL

EPIDE

RNMI

Michitaka Nagase Japan

J.-F. Bosset France

Kinji Nishiyama Japan

J. F. Gigot Belgium

Alec McDonald United Kingdom

Jessica M. Frakes United States

Mustafa Suker Netherlands

Lisa Zuraw Canada

Dennis A. Wicherts Netherlands

Aparna Balachandran United States

Michitaka Nagase Japan

J I Geh

666 ×0.5

SURGE

836 ×0.9

PRM

640 ×0.8

ONCOL

178 ×1.1

EPIDE

64 ×0.5

RNMI

Citations per year, relative to J I Geh J I Geh (= 1×) peers Michitaka Nagase

Countries citing papers authored by J I Geh

Since Specialization

Citations

This map shows the geographic impact of J I Geh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J I Geh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J I Geh more than expected).

Fields of papers citing papers by J I Geh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J I Geh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J I Geh. The network helps show where J I Geh may publish in the future.

Co-authorship network of co-authors of J I Geh

This figure shows the co-authorship network connecting the top 25 collaborators of J I Geh. A scholar is included among the top collaborators of J I Geh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J I Geh. J I Geh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Radley, Stephen, et al.. (2023). Management of small (T1–T2) anal margin squamous cell carcinoma: clinical outcomes following local excision alone. Colorectal Disease. 25(7). 1403–1413. 2 indexed citations

Crosby, Tom, Chris Hurt, Stephen Falk, et al.. (2017). Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer. British Journal of Cancer. 116(6). 709–716. 51 indexed citations

Pasquali, Sandro, Ravinder Vohra, Simone Mocellin, et al.. (2016). Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma. Annals of Surgery. 265(3). 481–491. 129 indexed citations

Rees, Jonathan, Chris Hurt, Simon Gollins, et al.. (2015). Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer. British Journal of Cancer. 113(4). 603–610. 29 indexed citations

Benghiat, Helen, Peter Nightingale, A. Hartley, et al.. (2014). Linear Accelerator Stereotactic Radiosurgery for Vestibular Schwannomas: A UK Series. Clinical Oncology. 26(6). 309–315. 19 indexed citations

Glynne‐Jones, Rob, Latha Kadalayil, Helen Meadows, et al.. (2014). Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial. Annals of Oncology. 25(8). 1616–1622. 36 indexed citations

Crosby, T., Chris Hurt, Stephen Falk, et al.. (2013). Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial. The Lancet Oncology. 14(7). 627–637. 272 indexed citations

Geh, J I & Yuk Ting. (2011). Evolution of systemic therapy for metastatic colorectal cancerdoi. Colorectal Disease. 13(8). 852–854. 1 indexed citations

Sanghera, Paul, Douglas W. Wong, Christopher C. McConkey, J I Geh, & A. Hartley. (2008). Chemoradiotherapy for Rectal Cancer: An Updated Analysis of Factors Affecting Pathological Response. Clinical Oncology. 20(2). 176–183. 151 indexed citations

10.

Tanière, Philippe, et al.. (2008). Use of Imatinib Mesylate in Gastrointestinal Stromal Tumours: Pan-Birmingham Cancer Network Experience. Clinical Oncology. 20(7). 517–522. 10 indexed citations

11.

Osman, Faizel, et al.. (2006). An unusual cause of cardiac paradox. European Journal of Echocardiography. 8(2). 91–92. 2 indexed citations

12.

Geh, J I, Simon Bond, Søren M. Bentzen, & Rob Glynne‐Jones. (2006). Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: Evidence of a radiation and chemotherapy dose response. Radiotherapy and Oncology. 78(3). 236–244. 135 indexed citations

13.

Hartley, A., et al.. (2005). Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials. British Journal of Radiology. 78(934). 934–938. 150 indexed citations

14.

Clark, Matthew A., A. Hartley, & J I Geh. (2004). Cancer of the anal canal. The Lancet Oncology. 5(3). 149–157. 141 indexed citations

15.

Wilson, Daisy, Louise Hiller, & J I Geh. (2004). Review of second-line chemotherapy for advanced gastric adenocarcinoma. Clinical Oncology. 17(2). 81–90. 57 indexed citations

16.

Hussain, Syed A., Deborah Stocken, Peter Riley, et al.. (2004). A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer. British Journal of Cancer. 91(5). 844–849. 80 indexed citations

17.

Hartley, A., Selvaraj Giridharan, Narayanan Srihari, C. McConkey, & J I Geh. (2003). Impaired postoperative neutrophil leucocytosis and acute complications following short course preoperative radiotherapy for operable rectal cancer. European Journal of Surgical Oncology. 29(2). 155–157. 19 indexed citations

18.

Geh, J I. (2002). The use of chemoradiotherapy in oesophageal cancer. European Journal of Cancer. 38(2). 300–313. 54 indexed citations

19.

Geh, J I & Rob Glynne‐Jones. (1998). Cervical spine involvement in metastatic colorectal carcinoma. Clinical Oncology. 10(2). 125–128. 6 indexed citations

20.

Bygrave, Helen, J I Geh, Yogini Jani, & Rob Glynne‐Jones. (1998). Neurological complications of 5-fluorouracil chemotherapy: Case report and review of the literature. Clinical Oncology. 10(5). 334–336. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact